---
title: "Upexi Engages Hivemind Capital in Three-Year Advisory Agreement, Paying 1.25% in Stock"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290878621.md"
description: "Upexi has entered into a three-year advisory agreement with Hivemind Capital Partners to assist with business, operations, and capital markets strategies. Compensation is set at 1.25% of Upexi's annual market capitalization, paid quarterly in stock subject to a 9.99% ownership cap, with excess paid in cash. The deal includes registration rights and acceleration clauses upon a takeout event."
datetime: "2026-06-25T20:43:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290878621.md)
  - [en](https://longbridge.com/en/news/290878621.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290878621.md)
generator: "portal-rs"
---

# Upexi Engages Hivemind Capital in Three-Year Advisory Agreement, Paying 1.25% in Stock

Upexi entered into a three-year Advisory Services Agreement with Hivemind Capital Partners to support business, operations, and capital markets strategies. Compensation equals 1.25% of Upexi's market capitalization annually, paid quarterly in stock based on quarter-end market cap, subject to a 9.99% ownership cap with any excess paid in cash. The shares carry registration rights, and fees are accelerated in cash upon a takeout. The agreement may be renewed annually and includes termination rights for disqualifying actions or uncured material breach.

**Agreement details:**

-   **Agreement type**: Advisory services agreement for business and capital markets strategy
-   **Counterparty**: Hivemind Capital Partners
-   **Signed / Effective**: Jun 22 2026 / same
-   **Duration / Termination**: 3 years, renewable annually
-   **Reason**: Strengthen strategy and capital markets execution

Original SEC Filing: UPEXI, INC. \[ UPXI \] - 8-K - Jun. 25, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [UPXI.US](https://longbridge.com/en/quote/UPXI.US.md)
- [PXIU.US](https://longbridge.com/en/quote/PXIU.US.md)

## Related News & Research

- [Implantica to host Capital Markets Day after RefluxStop FDA approval](https://longbridge.com/en/news/296865775.md)
- [3 Next-Gen AI Stocks That 3G Capital Bought in Q2](https://longbridge.com/en/news/296496173.md)
- [Tomra reschedules Capital Markets Day 2026 update for investors and analysts](https://longbridge.com/en/news/296784355.md)
- [Tikehau Capital Advisors, linked to Antoine Flamarion and Mathieu Chabran, purchases EUR 32.2 million of Tikehau Capital shares](https://longbridge.com/en/news/297068946.md)
- [Saba Capital reports $1.74 million BlackRock ESG Capital Allocation Term Trust common share sale](https://longbridge.com/en/news/297207500.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**